New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus

Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:An Bras Dermatol
Autors principals: Pasin, Victor Pavan, Pereira, Amanda Regio, de Carvalho, Kalline Andrade, de Paiva, João Marcos Góes, Enokihara, Milvia Maria Simões e Silva, Porro, Adriana Maria
Format: Artigo
Idioma:Inglês
Publicat: Sociedade Brasileira de Dermatologia 2015
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540539/
https://ncbi.nlm.nih.gov/pubmed/26312705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20153672
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars